Stockreport

Eisai to trial orexin-2 receptor agonist in narcolepsy patients [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF Narcolepsy is a rare long-term brain condition that can prevent a person from choosing when to wake or sleep. It is characterised by excessive daytime sleepiness. Type [Read more]